SAN ANTONIO, March 25, 2026 – UT Health San Antonio, the academic ... biomedical sciences and public health that are leading change and ...
News
- UT Health San Antonio launches clinical trial to study rapamycin and healthy aging
- OG Acquisition 2 Corp Provides Update on Business Combination with Concenter ...
Ralph A. DeFronzo as Chief Medical Officer. He is a Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio, as well as ...
- bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath ...
SAN ANTONIO--(BUSINESS WIRE)--$BIAF #BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive ...
- Biotech Company Tivic Health Aims to Advance Immunotherapy Research Programs
In December 2025, Tivic formed a wholly owned subsidiary, Velocity Bioworks, in San Antonio. The subsidiary provides biomanufacturing services ...
- Onconetix names David White CEO as biotech firm pivots - Cincinnati Business Courier
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay · Washington, D.C. · Wichita. Sign In. Sign In Existing Members; Become ...